Author Archives: toddkreider

ChromaDex adds top Alzheimer’s Disease researcer to its science advisory board

Today’s NR news, mentioned by Dave in the comments: ChromaDex added Rudolph Tanzi, the Vice-Chair of Neurology and Director of the Genetics and Aging Research Unit at Massachusetts General Hospital and a professor of neurology at Harvard Medical School. He … Continue reading

Posted in health, Health Pills | Tagged , , , , | Leave a comment

NR supplier Chromadex Joins with Scripps on Breast Cancer Treatment:

Dave in comments pointed to this, which has been discussed in terms of the science but now the business partnership is official: “Felding’s patented discoveries [at Scripps] include the enhancement of NAD+ metabolism through treatment with NAD+ precursors to potentiate … Continue reading

Posted in health, Health Pills | Tagged , , , , , , | Leave a comment

Economist Alan Blinder Claims the U.S. population is growing at 0.3%

Princeton economist Alan Blinder explained on Diane Rhem’s NPR podcast that the U.S. population is growing at just 0.3% when explaining why the Trump budget projections of 3% GDP growth are way off. Actually, it it is his numbers that … Continue reading

Posted in growth | Tagged , , , | Leave a comment

ChromaDex goes retail; loses (first round!) in court case with Elysium

ChromaDex announced at its recent shareholders meeting that they are in the process of marketing NR/Niagen on their own and are cutting off sales of NR (Nicotinamide Riboside) to vendors like Elysium as well as the 40 or so others … Continue reading

Posted in health, Health Pills | Tagged , , , | 3 Comments

David Sinclair takes 500 mg of NMN and says his biological age went from 58 to 32

David Sinclair of resveratrol fame told The Washington Post at age 45 in 2015 that he was taking 1000 mg of resveratrol a day in 2015 yet in an interview printed yesterday, he said before taking 500 mg of NMN … Continue reading

Posted in Health Pills | Tagged , , , , , | 4 Comments

The New Yorker mentions Elysium Basis (NR)

The New Yorker has a recent article entitled “The Silicon Valley Quest to Live Forever”, which covers several angles of how various researchers are trying to extend human longevity. Elysium and its first product Basis was mentioned toward the end … Continue reading

Posted in Health Pills | Tagged , , , , | Leave a comment

ChromaDex to announce NR trial results this summer

OK sports fans, NR (a potential anti-aging vitamin B3 derivative) monopoly supplier ChromaDex has recently said that it will release the results of its 8 week 140 person trial of NR in groups of 35 at 100 mg, 300 mg, … Continue reading

Posted in Health Pills | Tagged , , , | Leave a comment